ATE255893T1 - Antikachektische zusammensetzung - Google Patents

Antikachektische zusammensetzung

Info

Publication number
ATE255893T1
ATE255893T1 AT97914591T AT97914591T ATE255893T1 AT E255893 T1 ATE255893 T1 AT E255893T1 AT 97914591 T AT97914591 T AT 97914591T AT 97914591 T AT97914591 T AT 97914591T AT E255893 T1 ATE255893 T1 AT E255893T1
Authority
AT
Austria
Prior art keywords
pct
bond
substituted
ring
group
Prior art date
Application number
AT97914591T
Other languages
English (en)
Inventor
Yu Momose
Etsuya Matsutani
Takashi Sohda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE255893T1 publication Critical patent/ATE255893T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT97914591T 1996-04-04 1997-04-03 Antikachektische zusammensetzung ATE255893T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8284596 1996-04-04
JP9027957A JPH09323930A (ja) 1996-04-04 1997-02-12 悪液質の予防・治療剤
PCT/JP1997/001148 WO1997037656A1 (en) 1996-04-04 1997-04-03 Anticachectic composition

Publications (1)

Publication Number Publication Date
ATE255893T1 true ATE255893T1 (de) 2003-12-15

Family

ID=26365962

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97914591T ATE255893T1 (de) 1996-04-04 1997-04-03 Antikachektische zusammensetzung

Country Status (7)

Country Link
US (2) US6110948A (de)
EP (1) EP0893995B1 (de)
JP (1) JPH09323930A (de)
AT (1) ATE255893T1 (de)
AU (1) AU2177997A (de)
DE (1) DE69726716T2 (de)
WO (1) WO1997037656A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101066276A (zh) * 1994-07-01 2007-11-07 威尔斯塔特医疗公司 用于治疗全身性炎症和炎性肝炎的嘧啶核苷酸前体
ES2259459T3 (es) * 1997-11-19 2006-10-01 Takeda Pharmaceutical Company Limited Nuevos inhibidores de apoptosis.
AU7595298A (en) * 1997-12-02 1998-12-11 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hy pertension
US6887893B1 (en) * 1997-12-24 2005-05-03 Sankyo Company, Limited Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia
US6897019B1 (en) * 1998-04-17 2005-05-24 Tufts College Methods for treating and preventing insulin resistance and related disorders
US7105552B2 (en) * 1998-05-08 2006-09-12 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US7407978B2 (en) * 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
TWI249401B (en) 1999-04-14 2006-02-21 Takeda Chemical Industries Ltd Agent for improving ketosis
US20030087942A1 (en) * 2001-08-31 2003-05-08 Washington University Method for the treatment and prevention of cachexia
US20080114055A1 (en) * 2006-11-10 2008-05-15 Zoltan Laboratories Llc Thioxanthone Compounds to Reverse Weight Loss
US20080207738A1 (en) * 2007-02-28 2008-08-28 Cancure Laboratories, Llc Drug combinations to treat drug resistant tumors
CA2688570A1 (en) * 2007-05-31 2008-12-04 F.P.L. Pharma Inc. Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof
JP2010533205A (ja) * 2007-07-12 2010-10-21 トラガラ ファーマシューティカルズ,インク. 癌、腫瘍、および腫瘍関連障害を治療するための方法および組成物
BR112022013755A2 (pt) * 2020-01-13 2022-10-11 Astromedical Biotechnology Ltd Métodos para o tratamento de caquexia e de câncer, e, composição farmacêutica

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
TW268952B (de) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
GB9308487D0 (en) * 1993-04-23 1993-06-09 Smithkline Beecham Plc Novel compounds
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
JP3029768B2 (ja) * 1994-04-18 2000-04-04 三共株式会社 悪液質改善剤
WO1996004909A1 (en) * 1994-08-12 1996-02-22 Takeda Chemical Industries, Ltd. Use of quinone and hydroquinone derivatives for the teatment of cachexia
TW403748B (en) * 1994-11-02 2000-09-01 Takeda Chemical Industries Ltd An oxazolidinedione derivative, its production and a pharmaceutical composition for lowering blood sugar and lipid in blood comprising the same

Also Published As

Publication number Publication date
WO1997037656A1 (en) 1997-10-16
AU2177997A (en) 1997-10-29
JPH09323930A (ja) 1997-12-16
US6365607B1 (en) 2002-04-02
EP0893995A1 (de) 1999-02-03
US6110948A (en) 2000-08-29
EP0893995B1 (de) 2003-12-10
DE69726716T2 (de) 2004-10-07
DE69726716D1 (de) 2004-01-22

Similar Documents

Publication Publication Date Title
DE69726716T2 (de) Antikachektische zusammensetzung
IL146319A0 (en) Quinoline derivatives as inhibitors of mek enzymes
NZ507735A (en) Indole derivatives useful for treating malignant and other diseases caused by pathological cell proliferation
IL144170A0 (en) 4-oxo-1,4-dihydro-3-quinolinecarboamides as antiviral agents
FR2672598B1 (de)
ES2105617T3 (es) Derivados de piperacina como antagonistas de 5-ht.
IL117875A0 (en) Pharmaceutical compositions for inhibiting th growth of cancers
AU1172999A (en) Novel apoptosis inhibitors
DE69833797D1 (de) Substituierte 2-benzylamino-2-phenyl-acetamidverbindungen
NZ333798A (en) Arylcycloalkane carboxylic esters, their use for the treatment of urinary incontinence or irritable bowel syndrome, and method of manufacture.
NO990578L (no) Diesel-brennstoff inneholdende oksygenerte forbindelser
CA2247946A1 (en) Anticachectic composition
NZ335252A (en) Substituted 3-thia-1,2,3,4-tetrahydrocarbazole, 6,7,8,9-tetrahydropyrido[1,2-a]indole, 4,5-dihydro-thiopyrano[3,4-b]indole, pyrano[3,4-b]indole or beta-carbolinyl derivatives
IE44180L (en) Azaprostaglandins.
SE8800863D0 (sv) 3-(2-haloethyl)-1,4-oxathiins and 2-(2-haloethyl)-1,4-dithiins and treatment of leukemia and tumors therewith
MY133207A (en) Substituted benzolactam compaunds
ZA957449B (en) Bicyclic carboxamides
NZ513724A (en) Anticonvulsant derivatives useful in treating essential tremor
ES2017032A6 (es) Procedimiento para la obtencion de 4,5-dihidro-3(2h)-piridazinonas.
MX9709468A (es) Composiciones farmaceuticas para minimizar la perdida osea.
GR3006582T3 (de)
DE69511689D1 (de) Phosphonyldipeptide zur bekämpfung von kardiovasvakuläre erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties